Skip to content

Clinical trials

Epilepsies, Myoclonic trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Myoclonic Country / region: Netherlands Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20161
20171
20191
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda2
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2
Jazz Pharmaceuticals1
Longboard Pharmaceuticals1
Stichting Epilepsie Instellingen Nederland1
Zogenix, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Myoclonic8
Epilepsy5
Lennox Gastaut Syndrome3
Seizures3
Brain Diseases2
Arrhythmias, Cardiac1
Neurodevelopmental Disorders1
Sudden Unexpected Death in Epilepsy1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.